TSCO Q1 2026 Earnings EPS Misses Estimates by 11 Stock Holds Flat Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Origin Materials Q4 2025 Earnings Massive EPS Miss and Zero Revenue Highlight Ongoing Challenges SNY Q1 2026 Earnings EPS Beat on Strong Operational Execution Amid Broader Headwinds RCI Hospitality Holdings RICK Q3 2025 Earnings Significant EPS Miss Amid Operational Challenges